Pharma Stock Poised for 200% Leap – Analyst Highlights Massive Upside
Analyst sees over 100% upside potential in this pharma stock,Find out why Saqib Iqbal believes Royalty Pharma PLC (NASDAQ: RPRX) is an undervalued pharma stock with over 100% upside potential.